Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial

Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial Publié dans American Heart Journal, le 01 octobre 2010. En savoir plus en consultant le site. Auteurs : Beygui F, Vicaut E, Ecollan P, Machecourt J, Van Belle E, Zannad F, Montalescot G. Abstract BACKGROUND: Aldosterone is at its highest levels…

Usefulness of biomarker strategy to improve GRACE score’s prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.

Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Publié dans American Journal of Cardiology, le 01 septembre 2010. En savoir plus en consultant le site. Auteurs : Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, Bhatt D, Vicaut E,…

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. Publié dans American Heart Journal, le 01 janvier 2010. En savoir plus en consultant le site. Auteurs : White HD, Aylward PE, Gallo R, Bode…